Patent Ownership Disputes
NEWS -Brad Van Pelt outlines the biggest risks for companies working with outside consultants during product development and why patent ownership disputes can make or break consumer product launches, in the Journal of
Brad Van Pelt outlines the biggest risks for companies working with outside consultants during product development and why patent ownership disputes can make or break consumer product launches, in the Journal of
With the patent litigation changes that occurred at the Supreme Court level in 2018, Docket Navigator executed a year in review that resulted in their annual Patent Litigation Special Report. The
INO Therapeutics v. Praxair Distribution: Trying to make sense out of subject matter eligibility By: Sarah A. Kagan February 22, 2019 — Praxair Distribution Inc. challenged a set of patent claims
Craig W. Kronenthal discusses a recent decision that involved a patent application from Ford Global Technologies LLC on a method for facilitating software updates in a vehicle’s computer system. The
“First PTAB Reversals Under New Subject Matter Eligibility Guidance” written by Aseet Patel and Craig Kronenthal published in IP Watchdog. Click here to read the full article.
Athena v. Mayo: Are pure diagnostic claims per se ineligible for patenting? By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit issued its decision in Athena
First PTAB Decision Reversing Examiner Under New Subject Matter Eligibility Guidance By Craig W. Kronenthal and Aseet Patel February 2, 2019 – The Patent Trial and Appeal Board (PTAB), in
Banner & Witcoff is recognized as a top trademark firm in the 2019 edition of World Trademark Review 1000 – The World’s Leading Trademark Professionals. The WTR 1000 focuses exclusively on identifying the
Matthew P. Becker, Joseph J. Berghammer, Aaron Bowling, Marc S. Cooperman, Azuka C. Dike, Audra C. Eidem Heinze, Brian J. Emfinger, Katie Laatsch Fink, Sean J. Jungels, Kevin C. Keenan,
Sarah A. Kagan is quoted in an article on the Supreme Court case Helsinn Healthcare v. Teva Pharmaceuticals. Click here to read the article.